Bay Area startup Channel Medsystems' technology freezes the uterine lining to prevent excess menstrual building. It just raised $23.9 million for this device, which can be used in less than three minutes.
Channel Medsystems, a TheraNova spinout, is “white hot,” TheraNova President and CEO Dr. Daniel Burnett said. The company aims to treat heavy menstrual bleeding (HMB) using cryoablation. But why is the proverbial iron hot now? Last month, Channel MedSystems completed its feasibility study on four patients in Canada, CEO Ric Cote said. And, pending FDA […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.